Florida Cancer Specialists & Research Institute, LLC (FCS) advances gastrointestinal cancer treatment through participation ...

The healthcare sector is facing a decisive moment. While nursing shortages continue to dominate national conversations and ...

Part of the challenge lies with identifying otherwise healthy individuals — especially women — who lack standard modifiable ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutationsKB407 transduction confirmed in all ...

Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer using its Helicontm peptide platform to drug historically ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...

From major acquisitions to AI-powered partnerships, here are 10 major GI deals to know from 2025: 1. In January, Optum subsidiary SCA Health, one of the largest ASC chains in the country, acquired ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that targeting a specific immune process ...

At the Jacobs School, we strive to validate the hard work and dedication of our medical students. Each year, exceptional ...

Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO® ...